Abstract
MicroRNAs (miRNAs) are 19–22 nucleotide non-coding RNA molecules that regulate the expression of protein-coding genes post-transcriptionally. It has been suggested that the majority of protein coding genes are regulated by miRNAs, thus they play important roles in the regulation of cell fate, cell survival, proliferation and differentiation. MiRNAs typically act intracellularly on messenger RNA, but they can be transported between cells via a number of mechanisms including microvesicles, exosomes and in a direct cell contact manner, through gap junctions. This chapter explores the roles of miRNAs in human amniotic fluid cells. We discuss the identification of the cellular origin of miRNAs in amniotic fluid and their potential use as diagnostic biomarkers to identify and monitor developmental, physiological and pathological conditions. Also, the role of miRNAs during reprogramming of amniotic fluid cells through induced pluripotency and early differentiation is presented. Finally, it is shown that amniotic fluid cells can be transfected to stably express and process exogenous miRNAs, followed by a summary on the potential of these cells to study the role of miRNAs in differentiation and drug testing and to deliver miRNAs to target cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Londin E, et al. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. PNAS. 2015; E1106–E1115 www.pnas.org/cgi/doi/10.1073/pnas.1420955112.
Zhang J, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13(1):17–24.
Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014;13(8):622–38.
Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015;16(7):421–33.
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.
Friedlander MR, et al. Evidence for the biogenesis of more than 1,000 novel human microRNAs. Genome Biol. 2014;15(4):R57.
Zeng Y. Principles of micro-RNA production and maturation. Oncogene. 2006;25(46):6156–62.
Gantier MP, et al. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 2011;39(13):5692–703.
Friedman RC, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105.
Guo WT, Wang XW, Wang Y. Micro-management of pluripotent stem cells. Protein Cell. 2014;5(1):36–47.
Javidi MA, et al. Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids. Med Oncol. 2014;31(12):295.
Collino F, et al. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One. 2010;5(7):e11803.
Simpson RJ, et al. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics. 2009;6(3):267–83.
Higa GS, et al. MicroRNAs in neuronal communication. Mol Neurobiol. 2014;49(3):1309–26.
Qin J, Xu Q. Functions and application of exosomes. Acta Pol Pharm. 2014;71(4):537–43.
Weber JA, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733–41.
Cortez MA, et al. MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8(8):467–77.
Keller S, et al. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med. 2011;9:86.
Lim PK, et al. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res. 2011;71(5):1550–60.
Hosoda T. The mircrine mechanism controlling cardiac stem cell fate. Front Genet. 2013;4:204.
Greco SJ, Rameshwar P. Analysis of the transfer of circulating microRNA between cells mediated by gap junction. Methods Mol Biol. 2013;1024:87–96.
Hong X, et al. Gap junctions modulate glioma invasion by direct transfer of microRNA. Oncotarget. 2015;6:15566.
Katakowski M, et al. Functional microRNA is transferred between glioma cells. Cancer Res. 2010;70(21):8259–63.
Nielsen MS, et al. Gap junctions. Compr Physiol. 2012;2(3):1981–2035.
Judson RL, et al. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol. 2009;27(5):459–61.
Wang Y, et al. miR-294/miR-302 promotes proliferation, suppresses G1-S restriction point, and inhibits ESC differentiation through separable mechanisms. Cell Rep. 2013;4(1):99–109.
Shenoy A, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol. 2014;15(9):565–76.
Tay Y, et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008;455(7216):1124–8.
Xu N, et al. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 2009;137(4):647–58.
Wang L, et al. Gene and MicroRNA profiling of human induced pluripotent stem cell-derived endothelial cells. Stem Cell Rev. 2015;11(2):219–27.
Trohatou O, et al. Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med. 2014;3(1):54–68.
Jezierski A, et al. Human amniotic fluid cells form functional gap junctions with cortical cells. Stem Cells Int. 2012;2012:607161.
Rennie K, et al. Therapeutic potential of amniotic fluid-derived cells for treating the injured nervous system. Biochem Cell Biol. 2013;91(5):271–86.
Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol. 2008;18(10):505–16.
Barh D, et al. MicroRNA let-7: an emerging next-generation cancer therapeutic. Curr Oncol. 2010;17(1):70–80.
Sanek NA, Young WS. Investigating the in vivo expression patterns of miR-7 microRNA family members in the adult mouse brain. Microrna. 2012;1(1):11–8.
Sekar D, et al. Role of microRNA 21 in mesenchymal stem cell (MSC) differentiation: a powerful biomarker in MSCs derived cells. Curr Pharm Biotechnol. 2015;16(1):43–8.
Di Bernardini E, et al. Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor beta2 (TGF-beta2) pathways. J Biol Chem. 2014;289(6):3383–93.
Polajeva J, et al. miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma. BMC Cancer. 2012;12:378.
Bhalala OG, et al. microRNA-21 regulates astrocytic response following spinal cord injury. J Neurosci. 2012;32(50):17935–47.
Buller B, et al. MicroRNA-21 protects neurons from ischemic death. FEBS J. 2010;277(20):4299–307.
Ge XT, et al. miR-21 improves the neurological outcome after traumatic brain injury in rats. Sci Rep. 2014;4:6718.
Joglekar MV, et al. The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets. 2009;1(2):137–47.
Bridge G, et al. The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood. 2012;120(25):5063–72.
Sun Y, et al. An updated role of microRNA-124 in central nervous system disorders: a review. Front Cell Neurosci. 2015;9:193.
Meza-Sosa KF, Pedraza-Alva G, Perez-Martinez L. microRNAs: key triggers of neuronal cell fate. Front Cell Neurosci. 2014;8:175.
Zare M, et al. A novel protocol to differentiate induced pluripotent stem cells by neuronal microRNAs to provide a suitable cellular model. Chem Biol Drug Des. 2015;86:232.
Tan CL, et al. MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science. 2013;342(6163):1254–8.
O’Neill LA. Boosting the brain’s ability to block inflammation via microRNA-132. Immunity. 2009;31(6):854–5.
Devalliere J, et al. Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation. FASEB J. 2014;28(2):908–22.
Liu T, et al. Human amniotic epithelial cell feeder layers maintain human iPS cell pluripotency via inhibited endogenous microRNA-145 and increased Sox2 expression. Exp Cell Res. 2012;318(4):424–34.
Götte M, et al. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene. 2010;29(50):6569–80.
Chen S, et al. MicroRNA-494 inhibits the growth and angiogenesis-regulating potential of mesenchymal stem cells. FEBS Lett. 2015;589(6):710–7.
Yang CS, Li Z, Rana TM. microRNAs modulate iPS cell generation. RNA. 2011;17(8):1451–60.
Yang CS, Rana TM. Learning the molecular mechanisms of the reprogramming factors: let’s start from microRNAs. Mol Biosyst. 2013;9(1):10–7.
Kuppusamy KT, et al. Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes. Proc Natl Acad Sci U S A. 2015;112(21):E2785–94.
Jezierski A, et al. Neuroprotective effects of GDNF-expressing human amniotic fluid cells. Stem Cell Rev. 2014;10(2):251–68.
Smith B, et al. Large-scale expression analysis reveals distinct microRNA profiles at different stages of human neurodevelopment. PLoS One. 2010;5(6):e11109.
Davis CJ, Clinton JM, Krueger JM. MicroRNA 138, let-7b, and 125a inhibitors differentially alter sleep and EEG delta-wave activity in rats. J Appl Physiol (1985). 2012;113(11):1756–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ribecco-Lutkiewicz, M. et al. (2016). MicroRNA Expression in Amniotic Fluid Cells. In: Fauza, D., Bani, M. (eds) Fetal Stem Cells in Regenerative Medicine. Stem Cell Biology and Regenerative Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3483-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3483-6_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3481-2
Online ISBN: 978-1-4939-3483-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)